Haleon plc

LSE HLN.L

Haleon plc Market Capitalization on January 14, 2025: USD 40.53 B

Haleon plc Market Capitalization is USD 40.53 B on January 14, 2025, a 4.71% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Haleon plc 52-week high Market Capitalization is USD 48.17 B on September 27, 2024, which is 18.87% above the current Market Capitalization.
  • Haleon plc 52-week low Market Capitalization is USD 36.09 B on January 25, 2024, which is -10.94% below the current Market Capitalization.
  • Haleon plc average Market Capitalization for the last 52 weeks is USD 40.72 B.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
LSE: HLN.L

Haleon plc

CEO Mr. Brian James McNamara
IPO Date July 18, 2022
Location United Kingdom
Headquarters Building 5
Employees 25,408
Sector Health Care
Industries
Description

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Similar companies

RKT.L

Reckitt Benckiser Group plc

USD 59.37

-0.51%

MNG.L

M&G plc

USD 2.36

1.48%

LGEN.L

Legal & General Group Plc

USD 2.73

1.22%

GSK.L

GSK plc

USD 15.79

-2.73%

StockViz Staff

January 15, 2025

Any question? Send us an email